Sangamo Therapeutics
SGMO
#8675
Rank
NZ$0.29 B
Marketcap
NZ$0.89
Share price
4.39%
Change (1 day)
-57.66%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.73. In 2024 the company made an earnings per share (EPS) of NZ-$0.85.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-9.93%
2024NZ-$0.85
2022NZ-$2.080.81%
2021NZ-$2.0633.33%
2020NZ-$1.546.9%
2019NZ-$1.4522.54%
2018NZ-$1.181.43%
2017NZ-$1.16-31.37%
2016NZ-$1.6975.86%
2015NZ-$0.9648.72%
2014NZ-$0.65-17.02%
2013NZ-$0.789.3%
2012NZ-$0.71-39.44%
2011NZ-$1.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.34-2,472.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.64-3,061.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.25-2,597.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$2.69 268.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$10.83-1,581.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61-1,825.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.15-120.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.52-718.18%๐Ÿ‡บ๐Ÿ‡ธ USA